|
Tuesday, October 16, 2007 |
|
|
| 7:00 – 8:00 AM | Registration and Continental Breakfast | | 8:00 – 8:15 AM | Welcome
Milton D. Rossman, MD |
All abstract presentations are not CME certified
SESSION 1
Overview of Beryllium Uses: Health Effects
Moderator: Milton D. Rossman, MD
| 8:15 – 9:00 AM | Beryllium Properties and Uses
Mark D. Hoover, PhD, CHP, CIH | | 9:00 – 9:45 AM | History of Beryllium Disease
Milton Rossman, MD | | 9:45 – 10:00 AM | BREAK | | 10:00 – 10:45 AM | Epidemiology of Beryllium Sensitization
Kathleen Kreiss, MD | | 10:45 - 11:30 AM | Diagnosis and Management of Chronic Beryllium Disease
Raed Dweik, MD | | 11:30 - 12:00 PM | Living With Beryllium Disease
Lee S. Newman, MD, MA
Regina Hill | | 12:00 – 1:00 PM | LUNCH |
SESSION 2
Immunology and Genetics of CBD
Moderator: Andrew P. Fontenot, MD
| 1:00 – 1:40 PM | Keynote Lecture: T-cell Recognition of Metals
Lawrence J. Stern, PhD | | 1:40 – 2:05 PM | HLA DP Presentation of Beryllium
Massimo Amicosante, PhD | | 2:05 – 2:30 PM | Recombinant HLA-DP2 Binds Beryllium and Tolerizes Beryllium-Specific Pathogenic CD4 T Cells
Gregory G. Burrows, PhD | | 2:30 – 3:00 PM | BREAK |
SESSION 3
Genetics of CBD
Moderator: Andrew P. Fontenot, MD
| 3:00 – 3:30 PM | Genetic Risk Factors for Beryllium Sensitization, Chronic Beryllium Disease and Disease Severity
Lisa A. Maier, MD, MSPH, FCCP
| | 3:30 – 4:00 PM | HLA DP Associations
Ainsley Weston, PhD | | 4:00 – 4:30 PM | Gene Environmental Interactions
Kenneth Rosenman, MD | | 4:30 – 5:00 PM | Genotoxicity and Carcinogenicity
Terry Gordon, PhD | | 5:00 PM | ADJOURNMENT | | 5:15 – 7:00 PM | Welcome Reception |
|
